These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 12438254

  • 1. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
    Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ, Knudsen ES.
    Cancer Res; 2002 Nov 15; 62(22):6587-97. PubMed ID: 12438254
    [Abstract] [Full Text] [Related]

  • 2. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R.
    Cancer Metastasis Rev; 2005 Jun 15; 24(2):339-56. PubMed ID: 15986142
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway.
    Young AP, Nagarajan R, Longmore GD.
    Oncogene; 2003 Oct 16; 22(46):7209-17. PubMed ID: 14562049
    [Abstract] [Full Text] [Related]

  • 4. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S, Nath N, Adlam M, Chellappan S.
    Oncogene; 1999 Jun 10; 18(23):3501-10. PubMed ID: 10376528
    [Abstract] [Full Text] [Related]

  • 5. RBP1 induces growth arrest by repression of E2F-dependent transcription.
    Lai A, Marcellus RC, Corbeil HB, Branton PE.
    Oncogene; 1999 Mar 25; 18(12):2091-100. PubMed ID: 10321733
    [Abstract] [Full Text] [Related]

  • 6. The Rb/chromatin connection and epigenetic control: opinion.
    Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S, Harel-Bellan A.
    Oncogene; 2001 May 28; 20(24):3128-33. PubMed ID: 11420729
    [Abstract] [Full Text] [Related]

  • 7. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J, Yan PS, Cechvala M, Huang T, Farnham PJ.
    Oncogene; 2003 Mar 13; 22(10):1445-60. PubMed ID: 12629508
    [Abstract] [Full Text] [Related]

  • 8. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG, Xiong W, Liu HY, Huang H, Zhou M, Li GY.
    J Cell Physiol; 2004 Jul 13; 200(1):89-98. PubMed ID: 15137061
    [Abstract] [Full Text] [Related]

  • 9. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN, McCabe MT, Hayward SW, Park JM, Day ML.
    Cancer Res; 2005 May 01; 65(9):3633-42. PubMed ID: 15867358
    [Abstract] [Full Text] [Related]

  • 10. The lin-35/Rb and RNAi pathways cooperate to regulate a key cell cycle transition in C. elegans.
    Ouellet J, Roy R.
    BMC Dev Biol; 2007 Apr 27; 7():38. PubMed ID: 17466069
    [Abstract] [Full Text] [Related]

  • 11. Differences in stability of repressor complexes at promoters underlie distinct roles for Rb family members.
    Young AP, Longmore GD.
    Oncogene; 2004 Jan 22; 23(3):814-23. PubMed ID: 14737116
    [Abstract] [Full Text] [Related]

  • 12. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M.
    Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176
    [Abstract] [Full Text] [Related]

  • 13. Expression of p16 induces transcriptional downregulation of the RB gene.
    Fang X, Jin X, Xu HJ, Liu L, Peng HQ, Hogg D, Roth JA, Yu Y, Xu F, Bast RC, Mills GB.
    Oncogene; 1998 Jan 08; 16(1):1-8. PubMed ID: 9467937
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional control by cell-cycle regulators: a review.
    Lania L, Majello B, Napolitano G.
    J Cell Physiol; 1999 May 08; 179(2):134-41. PubMed ID: 10199552
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression.
    Frolov MV, Dyson NJ.
    J Cell Sci; 2004 May 01; 117(Pt 11):2173-81. PubMed ID: 15126619
    [Abstract] [Full Text] [Related]

  • 16. The E2F1-3 transcription factors are essential for cellular proliferation.
    Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G.
    Nature; 2001 Nov 22; 414(6862):457-62. PubMed ID: 11719808
    [Abstract] [Full Text] [Related]

  • 17. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J, Cloos P, Toftegaard U, Klinkenberg D, Bracken AP, Trinh E, Heeran M, Di Stefano L, Helin K.
    Nucleic Acids Res; 2005 Nov 22; 33(17):5458-70. PubMed ID: 16179649
    [Abstract] [Full Text] [Related]

  • 18. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
    Araki K, Kawauchi K, Tanaka N.
    Oncogene; 2008 Sep 25; 27(43):5696-705. PubMed ID: 18542057
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E, Lipp M, Cremisi C.
    Oncogene; 1994 Aug 25; 9(8):2235-43. PubMed ID: 8036009
    [Abstract] [Full Text] [Related]

  • 20. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression.
    Wang S, Fusaro G, Padmanabhan J, Chellappan SP.
    Oncogene; 2002 Dec 05; 21(55):8388-96. PubMed ID: 12466959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.